U.S. oil and gas producer ConocoPhillips is in advanced talks to sell assets in Oklahoma to privately owned Stone Ridge ...

During the last three months, 17 analysts shared their evaluations of ConocoPhillips COP, revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the table below ...

Shares of ConocoPhillips COP slipped 1.32% to $94.53 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,263. ...

How ConocoPhillips' Low-Cost Inventory Drives Competitive Advantage July 10, 2025 — 09:55 am EDT Written by Nilanjan Banerjee for Zacks -> ...

In this context, established energy leaders such as ExxonMobil (XOM), Chevron (CVX), and ConocoPhillips (COP) offer a strategic way to maintain exposure to potential upside in oil prices amid ...

Eastern Montana gets a new ConocoPhillips office. Western North Dakota gets the Bakken oil field action and most of the money. The Houston-based oil giant this week dedicated its new Billings ...

Jim Parkinson, the designer behind Rolling Stone's iconic logo, has died at 83 after a long battle with Alzheimer’s, his friend confirmed.

In the latest trading session, ConocoPhillips (COP) closed at $94.44, marking a +2.66% move from the previous day. This move outpaced the S&P 500's daily gain of 0.48%. Meanwhile, the Dow ...

The boss of Nottingham Building Society, which came under fire for axing Robin Hood from its logo, has said the controversial change has made it more popular than ever. In October last year ...

However, results from an internet search suggest that the facility — based around ConocoPhillips' Cascade liquefaction process — could potentially be built on the La Quinta ship channel in ...

BILLINGS — A fire at the ConocoPhillips refinery that spewed thick black smoke into the air on Christmas Eve was caused when a heater inside the tank ignited oil vapors, ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments ...